$982,669,952 in Total Settlement Funds Available. See if you qualify!Find Out More

Athira Pharma, Inc. Settlement
(NASDAQ: ATHA)
Settlement

Claim Deadline: September 06, 2024

Settlement Fund: $10,000,000

Settlement Class

All persons or entities that purchased or otherwise acquired Athira common stock from September 17, 2020, through June 17, 2021, inclusive.

Important Documents

Settlement Status

Final Approval

Class Period

September 17, 2020 - September 15, 2021

Settlement Hearing Date

October 25, 2024

Opt-Out Deadline

September 06, 2024

Claims Admin

Strategic Claims Services
Athira Pharma Securities Litigation
c/o Strategic Claims Services
P.O. Box 230
600 N. Jackson Street, Suite 205
Media, PA 19063
+1 866-274-4004
info@strategicclaims.net


Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.